Yahoo Web Search

  1. Merck, Pfizer Slide on Pelosi’s ‘Scary’ Drug-Pricing Plan

    Bloomberg via Yahoo FinanceSep 10 14:00 PM

    Drugmakers from Merck & Co. to Pfizer Inc. were under pressure in Tuesday's trading after documents showed House leader Nancy Pelosi's drug pricing plan appears skewed “ ...

  2. Merck Sees Hammer Chart Pattern: Time to Buy?

    Zacks via Yahoo FinanceSep 11 13:24 PM

    Merck & Co., Inc. MRK has been struggling lately, but the selling pressure may be coming to an end soon. What is a Hammer Chart Pattern? A hammer chart pattern is a popular ...

  3. MSFT, Merck & Co. Inc. MRK, The Procter & Gamble Co. PG, United Technologies Corp. UTX and The Coca-Cola Co. KO.

  4. Retina Society Annual Meeting 2019 Annual Meeting – Sept. in London Global Summit On Cardiology & Heart Diseases – Sept. in Dubai European Association for the Study of Diabetes, or EASD, 55th annual meeting – Sept.

  5. Lululemon Athletica Inc.

  6. Roche Holding AG RHHBY announced that its new investigational fixed-dose combination (FDC) of Perjeta (pertuzumab) and Herceptin (trastuzumab) has met the primary endpoint of non-inferiority ...

  7. Stocks recently featured in the blog include: Allergan AGN, Merck MRK and Roche RHHBY, J&J JNJ and Bristol-Myers BMY. This week, Allergan settled with two counties of Ohio for $5 million ...

  8. Lilly's RET Inhibitor Shrinks Tumors in Lung Cancer Study

    Zacks via Yahoo FinanceSep 09 20:39 PM

    Eli Lilly and Company's LLY oral RET inhibitor selpercatinib (LOXO-292) demonstrated a 68% objective response rate (ORR) or shrinkage in tumor size in heavily pretreated patients with RET fusion-positive ...

  9. Horizon (HZNP) Up 36.7% YTD: Pipeline Development in Focus

    Zacks via Yahoo FinanceSep 12 14:02 PM

    Shares of Horizon Therapeutics plc HZNP have surged 36.7% year to date against the industry’s decline of 1.9%. The company has been focusing on expanding its orphan drug business. This is evident ...

  10. Roche (RHHBY) Reports Positive Data on Tecentriq & MS Drug

    Zacks via Yahoo FinanceSep 12 13:09 PM

    Roche RHHBY announced positive data on the immuno-oncology drug, Tecentriq (atezolizumab), from a late-stage study in patients with advanced non-small cell lung cancer (NSCLC). The phase III ...

  1. Ad
    related to MERCK & CO., INC